[1] Feig DI, Kang DH, Johnson RJ. Uric Acid and Cardiovascular Risk. New Engl J Med, 2008; 359, 1811-21. doi:  10.1056/NEJMra0800885
[2] White J, Sofat R, Hemani G, et al. Plasma urate concentration and risk of coronary heart disease:a Mendelian randomisation analysis. Lancet Diabetes Endocrinol, 2016; 4, 327-36. doi:  10.1016/S2213-8587(15)00386-1
[3] Herman JB, Goldbourt U. Uric acid and diabetes:observations in a population study. The Lancet, 1982; 2, 240-3. https://www.sciencedirect.com/science/article/pii/S0140673682903245
[4] Juraschek SP, McAdams-Demarco M, Miller ER, et al. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol, 2014; 179, 684-91. doi:  10.1093/aje/kwt320
[5] Ndrepepa G, Braun S, King L, et al. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. Clini Sci, 2013; 124, 259-68. doi:  10.1042/CS20120336
[6] Zoppini G, Targher G, Negri C, et al. Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients. Diabetes Care, 2009; 32, 1716-20. doi:  10.2337/dc09-0625
[7] Zoppini G, Targher G, Bonora E. The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects:a narrative review. J Endocrinol Invest, 2011; 34, 881-6. doi:  10.1007/BF03346733
[8] Kuwabara M, Kuwabara R, Hisatome I, et al. 'Metabolically Healthy' Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes:5-year Japanese Cohort Study. Obesity (Silver Spring), 2017; 25, 1997-2008. doi:  10.1002/oby.v25.11
[9] Braga F, Pasqualetti S, Ferraro S, et al. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population:a systematic review and meta-analysis. Clin Chem Lab Med, 2016; 54, 7-15. http://www.ncbi.nlm.nih.gov/pubmed/26351943
[10] Storhaug HM, Norvik JV, Toft I, et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population:a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord, 2013; 13, 15. doi:  10.1186/1471-2261-13-15
[11] Jin M, Yang F, Yang I, et al. Uric Acid, Hyperurice-mia and Vascular Diseases. Front Biosci, 2012; 7, 656-69.
[12] Culleton BF, Larson MG, Kannel, WB, et al. Serum uric acid and risk for cardiovascular disease and death:the Framingham Heart Study. Ann Intern Med, 1999; 131, 7-13. doi:  10.7326/0003-4819-131-1-199907060-00003
[13] Chou P, Lin KC, Lin HY, et al. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol, 2001; 28, 571-6. https://www.sciencedirect.com/science/article/pii/S1262363610002958
[14] Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol, 2001; 87, 1411-4. doi:  10.1016/S0002-9149(01)01566-1
[15] Lai X, Yang L, Legare S, et al. Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort. Int J Cardiol, 2016; 224, 299-304. doi:  10.1016/j.ijcard.2016.09.035
[16] Lu J, Zhang J, Du R, et al. Age at menarche is associated with the prevalence of nonalcoholic fatty liver disease later in life. J Diabetes, 2017; 9, 53-60. doi:  10.1111/1753-0407.12379
[17] Chen Y, Lu J, Huang Y, et al. Association of previous schistosome infection with diabetes and metabolic syndrome:a cross-sectional study in rural China. J Clin Endocrinol Metab, 2013; 98, E283-7. doi:  10.1210/jc.2012-2517
[18] Lu J, Mu Y, Su Q, et al. Reduced Kidney Function Is Associated With Cardiometabolic Risk Factors, Prevalent and Predicted Risk of Cardiovascular Disease in Chinese Adults:Results From the REACTION Study. J Am Heart Assoc, 2016; 5. http://www.ncbi.nlm.nih.gov/pubmed/27451464
[19] Lu J, Bi Y, Wang T, et al. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population:results of the REACTION study. Int J Cardiol, 2014; 172, 388-94. doi:  10.1016/j.ijcard.2014.01.073
[20] Expert Panel on Detection E. Treatment of High Blood Cholesterol in A:Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). JAMA, 2001; 285, 2486-97. doi:  10.1001/jama.285.19.2486
[21] Goff DC, Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2014; 129, S49-73. doi:  10.1161/01.cir.0000437741.48606.98
[22] Chuang SY, Chen JH, Yeh WT, et al. Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. Int J Cardiol, 2012; 154, 316-21. doi:  10.1016/j.ijcard.2011.06.055
[23] Nan H, Dong Y, Gao W, et al. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract, 2007; 76, 68-74. doi:  10.1016/j.diabres.2006.07.022
[24] Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens, 2008; 26, 269-75. doi:  10.1097/HJH.0b013e3282f240bf
[25] Kanbay M, Segal M, Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart, 2013; 99, 759-66. doi:  10.1136/heartjnl-2012-302535
[26] Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int, 2005; 67, 1739-42. doi:  10.1111/j.1523-1755.2005.00273.x
[27] Xu L, Shi Y, Zhuang S, et al. Recent advances on uric acid transporters. Oncotarget, 2017; 8, 100852-62. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725069/
[28] Rizzo M, Obradovic M, Labudovic-Borovic M, et al. Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome. Curr Vasc Pharma, 2014; 12, 572-85. doi:  10.2174/1570161111999131205160756